Influenza Vaccine Coverage among Pregnant Women in a Public Hospital System during the 2009-2010 Pandemic Influenza Season.

Influenza Res Treat

Department of Obstetrics/Gynecology and Women's Health, Maricopa Integrated Health System, Phoenix, AZ 85008, USA ; Department of Research, Maricopa Integrated Health System, Phoenix, AZ 85008, USA ; Department of Obstetrics and Gynecology, District Medical Group, Phoenix, AZ 85016, USA.

Published: October 2012

The purpose of this study was to compare influenza vaccination rates of pregnant women in a public safety-net health system to national coverage rates during the 2009-2010 pandemic influenza season. A chart review of a random sample of deliveries was undertaken to determine rates of coverage and predictors of vaccine coverage of women who obtained prenatal care and delivered in our health system. Rates were calculated from deliveries from when the vaccine was first available through April 30, 2010. Coverage rates were 54% for the seasonal influenza vaccine and 51% for the H1N1 vaccine. Race/ethnicity, insurance status and language spoken did not predict the receipt of either vaccine. When we included only births which occurred through March 12, 2010, as was done in a large population-based study, the rates were 61% and 59%, respectively. Our rates are about 10% higher than the rates reported in that study. Our comprehensive strategy for promoting vaccine coverage achieved higher vaccination rates in a safety-net health system, which serves groups historically less likely to be vaccinated, than those reported for the pregnant population at large.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447293PMC
http://dx.doi.org/10.1155/2012/329506DOI Listing

Publication Analysis

Top Keywords

vaccine coverage
12
health system
12
rates
9
influenza vaccine
8
pregnant women
8
women public
8
2009-2010 pandemic
8
pandemic influenza
8
influenza season
8
vaccination rates
8

Similar Publications

Background: In December 2020, Canada began its coronavirus disease 2019 (COVID-19) vaccine rollout campaign. Canadians were vaccinated with differing time intervals between doses, vaccine products and vaccine schedules, based on age, timing of vaccination and jurisdiction. The objective of this study is to describe the epidemiology and association between the incidence of COVID-19 cases following vaccination, time since completion of primary series, time between doses and/or product combination and probability of developing severe outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!